Bormioli Pharma Sales Surge 47% in North America on Expanded Capacity and Sustainability Focus
-
Bormioli Pharma announcing 47% sales growth in North America for 2023 due to expanded capacity and infrastructure
-
Tailoring product offerings to meet North American standards and demand, including FDA-approved warehouse and glass vials
-
Signed contract to supply packaging kits to US allergen immunotherapy leader
-
Committing to sustainability initiatives like 50% sustainable materials by 2025 (currently at 45%)
-
Partnering with Loop Industries to develop pharmaceutical packaging using 100% recycled plastic